Curis (CRIS) Sells Portion of Erivedge Royalties for up to $135.7 million

March 25, 2019 8:31 AM

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found